Soluble Aβ Oligomers Inhibit Long-term Potentiation Through a Mechanism Involving Excessive Activation of Extrasynaptic NR2B-containing NMDA Receptors

Overview

Journal J Neurosci

Specialty Neurology

Date 2011 May 6

PMID 21543591

Citations 350

Authors

Shaomin Li

Ming Jin

Thomas Koeglsperger

Nina E Shepardson

Ganesh M Shankar

Dennis J Selkoe

Affiliations

Soon will be listed here.

Abstract

In Alzheimer's disease (AD), dementia severity correlates strongly with decreased synapse density in hippocampus and cortex. Numerous studies report that hippocampal long-term potentiation (LTP) can be inhibited by soluble oligomers of amyloid β-protein (Aβ), but the synaptic elements that mediate this effect remain unclear. We examined field EPSPs and whole-cell recordings in wild-type mouse hippocampal slices. Soluble Aβ oligomers from three distinct sources (cultured cells, AD cortex, or synthetic peptide) inhibited LTP, and this was prevented by the selective NR2B inhibitors ifenprodil and Ro 25-6981. Soluble Aβ enhanced NR2B-mediated NMDA currents and extrasynaptic responses; these effects were mimicked by the glutamate reuptake inhibitor dl-threo-β-benzyloxyaspartic acid. Downstream, an Aβ-mediated rise in p38 mitogen-activated protein kinase (MAPK) activation was followed by downregulation of cAMP response element-binding protein, and LTP impairment was prevented by inhibitors of p38 MAPK or calpain. Thus, soluble Aβ oligomers at low nanomolar levels present in AD brain increase activation of extrasynaptic NR2B-containing receptors, thereby impairing synaptic plasticity.

Citing Articles

Investigating the Impact of NMDA Receptor Organization and Biological Sex in the APPswe/PS1dE9 Mouse Model of Alzheimer's Disease.

Hadzibegovic S, Bontempi B, Nicole O Int J Mol Sci. 2025; 26(4).

PMID: 40004200 PMC: 11855313. DOI: 10.3390/ijms26041737.

Natural Anti-NMDAR1 Autoantibodies Associate with Slowed Decline of Cognitive Functions in Alzheimer's Diseases.

Zhou X medRxiv. 2025; .

PMID: 39974092 PMC: 11838983. DOI: 10.1101/2025.01.16.25320688.

The spectrum-efficacy correlation of Kai-Xin-San for cognition of Aβ transgenic and verification of its active ingredients.

Wu J, Sun H, Zhao Y, Lian L, Bian H, Guo Y Front Pharmacol. 2025; 16:1538837.

PMID: 39936091 PMC: 11811076. DOI: 10.3389/fphar.2025.1538837.

AMPA receptor diffusional trapping machinery as an early therapeutic target in neurodegenerative and neuropsychiatric disorders.

Choquet D, Opazo P, Zhang H Transl Neurodegener. 2025; 14(1):8.

PMID: 39934896 PMC: 11817889. DOI: 10.1186/s40035-025-00470-z.

Neuronal LAG3 facilitates pathogenic α-synuclein neuron-to-neuron propagation.

Yang X, Jeong D, Madeo G, Kumbhar R, Wang N, Niu L bioRxiv. 2025; .

PMID: 39803449 PMC: 11722393. DOI: 10.1101/2025.01.03.631221.

References

Berberich S, Jensen V, Hvalby O, Seeburg P, Kohr G . The role of NMDAR subtypes and charge transfer during hippocampal LTP induction. Neuropharmacology. 2006; 52(1):77-86. DOI: 10.1016/j.neuropharm.2006.07.016. View

Harkany T, Abraham I, Timmerman W, Laskay G, Toth B, Sasvari M . beta-amyloid neurotoxicity is mediated by a glutamate-triggered excitotoxic cascade in rat nucleus basalis. Eur J Neurosci. 2000; 12(8):2735-45. DOI: 10.1046/j.1460-9568.2000.00164.x. View

Overstreet L, Pasternak J, COLLEY P, Slater N, Trommer B . Metabotropic glutamate receptor mediated long-term depression in developing hippocampus. Neuropharmacology. 1997; 36(6):831-44. DOI: 10.1016/s0028-3908(97)00031-2. View

Okamoto S, Pouladi M, Talantova M, Yao D, Xia P, Ehrnhoefer D . Balance between synaptic versus extrasynaptic NMDA receptor activity influences inclusions and neurotoxicity of mutant huntingtin. Nat Med. 2009; 15(12):1407-13. PMC: 2789858. DOI: 10.1038/nm.2056. View

Hensley K, Floyd R, Zheng N, Nael R, Robinson K, Nguyen X . p38 kinase is activated in the Alzheimer's disease brain. J Neurochem. 1999; 72(5):2053-8. DOI: 10.1046/j.1471-4159.1999.0722053.x. View

Klyubin I, Walsh D, Lemere C, Cullen W, Shankar G, Betts V . Amyloid beta protein immunotherapy neutralizes Abeta oligomers that disrupt synaptic plasticity in vivo. Nat Med. 2005; 11(5):556-61. DOI: 10.1038/nm1234. View

Snyder E, Nong Y, Almeida C, Paul S, Moran T, Choi E . Regulation of NMDA receptor trafficking by amyloid-beta. Nat Neurosci. 2005; 8(8):1051-8. DOI: 10.1038/nn1503. View

Lue L, Kuo Y, Roher A, Brachova L, Shen Y, Sue L . Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease. Am J Pathol. 1999; 155(3):853-62. PMC: 1866907. DOI: 10.1016/s0002-9440(10)65184-x. View

Okubo Y, Sekiya H, Namiki S, Sakamoto H, Iinuma S, Yamasaki M . Imaging extrasynaptic glutamate dynamics in the brain. Proc Natl Acad Sci U S A. 2010; 107(14):6526-31. PMC: 2851965. DOI: 10.1073/pnas.0913154107. View

10.

Ivanov A, Pellegrino C, Rama S, Dumalska I, Salyha Y, Ben-Ari Y . Opposing role of synaptic and extrasynaptic NMDA receptors in regulation of the extracellular signal-regulated kinases (ERK) activity in cultured rat hippocampal neurons. J Physiol. 2006; 572(Pt 3):789-98. PMC: 1779993. DOI: 10.1113/jphysiol.2006.105510. View

11.

Domingues A, Almeida S, da Cruz e Silva E, Oliveira C, Rego A . Toxicity of beta-amyloid in HEK293 cells expressing NR1/NR2A or NR1/NR2B N-methyl-D-aspartate receptor subunits. Neurochem Int. 2007; 50(6):872-80. DOI: 10.1016/j.neuint.2007.03.001. View

12.

Papadia S, Hardingham G . The dichotomy of NMDA receptor signaling. Neuroscientist. 2007; 13(6):572-9. PMC: 2830536. DOI: 10.1177/10738584070130060401. View

13.

Hardingham G, Fukunaga Y, Bading H . Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways. Nat Neurosci. 2002; 5(5):405-14. DOI: 10.1038/nn835. View

14.

Lu W, Man H, Ju W, Trimble W, MacDonald J, Wang Y . Activation of synaptic NMDA receptors induces membrane insertion of new AMPA receptors and LTP in cultured hippocampal neurons. Neuron. 2001; 29(1):243-54. DOI: 10.1016/s0896-6273(01)00194-5. View

15.

Janus C, Pearson J, McLaurin J, Mathews P, Jiang Y, Schmidt S . A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. Nature. 2001; 408(6815):979-82. DOI: 10.1038/35050110. View

16.

Goebel-Goody S, Davies K, Alvestad Linger R, Freund R, Browning M . Phospho-regulation of synaptic and extrasynaptic N-methyl-d-aspartate receptors in adult hippocampal slices. Neuroscience. 2008; 158(4):1446-59. DOI: 10.1016/j.neuroscience.2008.11.006. View

17.

Townsend M, Shankar G, Mehta T, Walsh D, Selkoe D . Effects of secreted oligomers of amyloid beta-protein on hippocampal synaptic plasticity: a potent role for trimers. J Physiol. 2006; 572(Pt 2):477-92. PMC: 1779683. DOI: 10.1113/jphysiol.2005.103754. View

18.

Izumi Y, Tokuda K, Zorumski C . Long-term potentiation inhibition by low-level N-methyl-D-aspartate receptor activation involves calcineurin, nitric oxide, and p38 mitogen-activated protein kinase. Hippocampus. 2007; 18(3):258-65. DOI: 10.1002/hipo.20383. View

19.

Min M, Rusakov D, Kullmann D . Activation of AMPA, kainate, and metabotropic receptors at hippocampal mossy fiber synapses: role of glutamate diffusion. Neuron. 1998; 21(3):561-70. DOI: 10.1016/s0896-6273(00)80566-8. View

20.

Lambert M, Barlow A, Chromy B, Edwards C, Freed R, Liosatos M . Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci U S A. 1998; 95(11):6448-53. PMC: 27787. DOI: 10.1073/pnas.95.11.6448. View